Uncategorized
Uncategorized · page 40
- Uncategorized
Alabama Cannabis Licences on Hold Again as Judge Issues Temporary Restraining Order
Alabama’s troubled medical cannabis licensing process has hit yet another roadblock as a judge has issued a temporary hold on issuing licences.
- Uncategorized
Cannabis Payments Processor Seeks $500m in Damages as It Closes Doors
Georgia-based cannabis payments processor FP Omni Technologies is seeking $500m in damages as it announces that it is winding down operations.
- Uncategorized
US Cannabis Stocks Spike as DEA Confirms Cannabis Reclassification Review
The US Drug Enforcement Administration (DEA) has confirmed that it is conducting a review into the reclassification of cannabis, but has asserted its ‘final authority’ over the decision.
- Uncategorized
Looking Ahead: What’s in Store for Cannabis in 2024? – Part 3
You can read part 1 of our Looking Ahead series here. Bryan Gerber – Founder & CEO, HARA Supply In preparation for 2024, cannabis operators are seeking to further cut costs and prioritize efficiency across the supply chain.
- Uncategorized
Looking Ahead: What’s in Store for Cannabis in 2024? – Part 2
You can read part 1 of our Looking Ahead series here. David Goubert, President & CEO, AYR Wellness MSOs will be focusing on the financial health of their companies, prioritizing cash flow generation and fostering leaner, more efficient operations.
- Uncategorized
Looking Ahead: What’s in Store for Cannabis in 2024? – Part 1
2023 has been a significant year for cannabis across North America.
- Uncategorized
SOMAÍ Pharmaceuticals und Canify geben ihre Partnerschaft zur Einführung einer auf Cannabinoiden basierenden Produktlinie in Deutschland bekannt
SOMAÍ Pharmaceuticals und Canify AG geben ihre strategische Partnerschaft zur Einführung einer differenzierten Produktlinie auf Cannabinoidbasis in Deutschland bekannt SOMAÍ Pharmaceuticals Unipessoal LDA (SOMAÍ”), ein europäisches Pharma- und Biotechnologieunternehmen mit EU-GMP-Standard, das cannabinoidhaltige Arzneimittel weltweit vertreibt, gibt eine bahnbrechende dreijährige Marketing- und Vertriebsvereinbarung mit der Canify AG (Canify”) bekannt, einem lizenzierten pharmazeutischen Unternehmen, das sich…
- Uncategorized
Florida Files Bill to Remove 280E Tax Burdens as DeSantis’ Ties to Medical Cannabis Industry Brought Into Question
A Florida State Senator has filed a proposal which would relieve the 280E tax burden on medical cannabis businesses.
- Uncategorized
Landmark Bill Allowing Medical Cannabis to Be Sold in Pharmacies Quashed by DEA in Georgia
Georgia’s ambitious plans to become the first US state to allow general pharmacies to dispense medical cannabis have been quashed by the Drug Enforcement Agency (DEA).
- Uncategorized
Six Synthetic Cannabinoids Placed in Schedule 1 in Effort to ‘Avoid Imminent Hazard to Public Safety’
The US Drug Enforcement Agency (DEA) has placed six ‘synthetic cannabinoids’ into a temporary Schedule 1 in an effort to ‘avoid imminent hazard to public safety’.
- Uncategorized
Ohio Appoints Former Head of Alcohol Regulator as New Cannabis Superintendent
The Ohio Department of Commerce has appointed James V. Canepa as the first superintendent for the newly formed Division of Cannabis Control.
- Uncategorized
Missouri Has Expunged 100,000 Cannabis Convictions, But Deadline Now Passed
The deadline has now been passed for Missouri to process its non-violent cannabis-related offences for expungement.
